Medicenna Therapeutics Corp. (TSX:MDNA)

Medicenna Therapeutics Statistics

Total Valuation

TSX:MDNA has a market cap or net worth of CAD 70.06 million. The enterprise value is 49.77 million.

Market Cap	70.06M
Enterprise Value	49.77M

Important Dates

The last earnings date was Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:MDNA has 83.41 million shares outstanding. The number of shares has increased by 11.70% in one year.

Current Share Class	83.41M
Shares Outstanding	83.41M
Shares Change (YoY)	+11.70%
Shares Change (QoQ)	+5.55%
Owned by Insiders (%)	14.33%
Owned by Institutions (%)	n/a
Float	56.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	4.79
P/TBV Ratio	4.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.80
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.81

Financial Position

The company has a current ratio of 4.94, with a Debt / Equity ratio of 0.01.

Current Ratio	4.94
Quick Ratio	4.73
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.80% and return on invested capital (ROIC) is -72.56%.

Return on Equity (ROE)	-69.80%
Return on Assets (ROA)	-44.98%
Return on Invested Capital (ROIC)	-72.56%
Return on Capital Employed (ROCE)	-120.21%
Revenue Per Employee	n/a
Profits Per Employee	-727,556
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.56% in the last 52 weeks. The beta is 1.70, so TSX:MDNA's price volatility has been higher than the market average.

Beta (5Y)	1.70
52-Week Price Change	-60.56%
50-Day Moving Average	0.89
200-Day Moving Average	1.28
Relative Strength Index (RSI)	46.62
Average Volume (20 Days)	25,383

Short Selling Information

The latest short interest is 222,810, so 0.29% of the outstanding shares have been sold short.

Short Interest	222,810
Short Previous Month	150,128
Short % of Shares Out	0.29%
Short % of Float	0.45%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.88M
Pretax Income	-13.10M
Net Income	-13.10M
EBITDA	-21.84M
EBIT	-21.88M
Earnings Per Share (EPS)	-0.17

Balance Sheet

The company has 20.46 million in cash and 162,000 in debt, giving a net cash position of 20.30 million or 0.24 per share.

Cash & Cash Equivalents	20.46M
Total Debt	162,000
Net Cash	20.30M
Net Cash Per Share	0.24
Equity (Book Value)	14.64M
Book Value Per Share	0.18
Working Capital	18.01M

Cash Flow

In the last 12 months, operating cash flow was -17.71 million and capital expenditures -2,000, giving a free cash flow of -17.71 million.

Operating Cash Flow	-17.71M
Capital Expenditures	-2,000
Free Cash Flow	-17.71M
FCF Per Share	-0.21

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:MDNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.70%
Shareholder Yield	n/a
Earnings Yield	-18.69%
FCF Yield	-25.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 3, 2017. It was a reverse split with a ratio of 0.0714285.

Last Split Date	Mar 3, 2017
Split Type	Reverse
Split Ratio	0.0714285

Scores

Altman Z-Score	n/a
Piotroski F-Score	1